Tina Liu

Neurology
550 17th Ave Ste 540
Seattle, WA 98122

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Familial Aggregation of Parkinson Disease and Essential Tremor in Early and Late Onset Parkinson Disease Cohorts.

Familial Aggregation of Parkinson Disease and Essential Tremor in Early and Late Onset Parkinson Disease Cohorts.

Journal: Neurology
Published: July 01, 2026

Chorea After MR-Guided Focused Ultrasound Thalamotomy.

Chorea After MR-Guided Focused Ultrasound Thalamotomy.

Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: August 14, 2025

VPS13C heterozygous loss of function as a modifier for suboptimal response to levodopa in Parkinson's disease.

VPS13C heterozygous loss of function as a modifier for suboptimal response to levodopa in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: July 21, 2025

Dopamine-responsive post-anoxic parkinsonism.

Dopamine-responsive post-anoxic parkinsonism.

Journal: Journal of Parkinson's disease
Published: April 24, 2025

Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy.

Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy.

Journal: Cerebellum (London, England)
Published: November 11, 2024

Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia.

Frontotemporal Hypometabolism in Medication-Induced Tardive Dyskinesia.

Journal: Neurology
Published: January 24, 2023

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.

Journal: JAMA neurology
Published: February 18, 2020
Showing 1-7 of 7

Last Updated: 09/26/2026